Efficiency of therapy with inactive vitamin D in chronic obstructive pulmonary disease concurrent with chronic kidney disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The authors have investigated the factors influencing the efficiency therapy and estimated the time of course of changes in the provision of vitamin D by the level of its active metabolite 25(OH)D3 in patients with chronic obstructive pulmonary disease concurrent with early renal dysfunction during treatment with drugs containing inactive vitamin D3.

Full Text

Restricted Access

About the authors

E. Bolotova

Kuban State Medical University

V. Yavlyanskaya

Kuban State Medical University; Territorial Clinical Hospital Two

A. Dudnikova

Kuban State Medical University

References

  1. Report GOLD: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org
  2. Zhu B., Zhu B., Xiao C. et al. Vitamin D. deficiency is associated with the severity of COPD: a systematic review and meta-analysis // Int. J. Chron. Obstruct. Pulmon. Dis. - 2015; 10: 1907-16. doi: 10.2147/COPD.S89763.
  3. Martineau A., James W., Hooper R. et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial // Lancet Respir. Med. - 2015; 3 (2): 120-30. doi: 10.1016/S2213-2600(14)70255-3.
  4. Yoshizawa T., Okada K., Furuichi S. et al. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C. levels // Int. J. Chron. Obstruct. Pulmon. Dis. - 2015; 10: 1283-9. doi: 10.2147/COPD. S80673.
  5. Моисеев В.С., Мухин Н.А., Мухин А.В. и др. Национальные рекомендации. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции // Клин. нефрол. - 2014; 2: 4-29
  6. Rafiq R., Prins H., Boersma W. et al. Effects of daily vitamin D. supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial // Int. J. Chron. Obstruct. Pulmon. Dis. - 2017; 12: 2583-92. doi: 10.2147/COPD.S132117.
  7. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease // Kidney Int. Suppl. - 2013; 84 (3): 622-3. DOI: 10.1038/ kisup.2012.37.
  8. Deb D., Chen Y., Zhang Z. et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway // Am. J. Physiol. Renal. Physiol. - 2009; 296 (5): F1212-8. doi: 10.1152/ajprenal.00002.2009.
  9. Graciano M., Cavaglieri Rde C., Delle H. et al. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis // J. Am. Soc. Nephrol. - 2004; 15 (7): 1805-15.
  10. Forman J., Williams J., Fisher N. Plasma 25-hydroxyvitamin D. and regulation of the renin-angiotensin system in humans // Hypertension. - 2010; 55 (5): 1283-8. doi: 10.1161/hypertensionaha.109.148619.
  11. Болотова Е.В., Дудникова А.В., Являнская В.В. Особенности исследования состава тела у больных хронической обструктивной болезнью легких. // Пульмонология. - 2018; 28 (4): 453-9 doi: 10.18093/08690189-2018-28-4-453-459.
  12. Bischoff-Ferrari H., Borchers M., Gudat F. et al. Vitamin D. receptor expression in human muscle tissue decreases with age // J. Bone Miner. Res. -2004; 19 (2): 265-9.
  13. Ceglia L., Niramitmahapanya S., da Silva Morais M. et al. Arandomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D. receptor concentration in older women // J. Clin. Endocrinol. Metab. - 2013; 98 (12): E1927-35. doi: 10.1210/jc.2013-2820.
  14. Corraini P., Henderson V., Ording A. et al. Long-term risk of dementia among survivors of ischemic or hemorrhagic stroke // Stroke. - 2017; 48 (1): 180-6. doi: 10.1161/strokeaha.116.015242.
  15. Annweiler C., Schott A., Berrut G. et al. Vitamin D. and ageing: neurological issues // Neuropsychobiology. - 2010; 62 (3): 139-50. doi: 10.1159/000318570.
  16. Алексеева Н. Взаимосвязь витамина D. и нарушений сна при метаболическом синдроме // Врач. - 2017; 9: 61-3
  17. Jorde R., Kubiak J. No improvement in depressive symptoms by vitamin D. supplementation: results from a randomised controlled trial // J. Nutr. Sci. - 2018; 7:e30. doi: 10.1017/jns.2018.19.
  18. Binkley N., Borchardt G., Siglinsky E. et al. Does vitamin d metabolite measurement help predict 25(OH)D change following vitamin D. supplementation? // Endocr. Pract. - 2017; 23 (4): 432-41. doi: 10.4158/ep161517.or.
  19. de Blasio F., de Blasio F., Miracco Berlingieri G. et al. Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis // Int. J. Chron. Obstruct. Pulmon. Dis. - 2016; 11: 2419-26. DOI: 10.2147/ copd.s110364.
  20. Дефицит витамина D. у взрослых: диагностика, лечение и профилактика. Клинические рекомендации / М., 2015
  21. Максимова М.Н., Струков В.И., Радченко Л.Г. Динамика содержания витамина D в сыворотке крови с транзиторным гипотиреозом в зависимости от способа профилактики рахита // Рос. вестн. перинатол. и педиат. - 2015; 60 (4): 159-60

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies